Moderna was down in Tuesday trading after a bearish call from BofA Securities sent shares lower. Analysts led by Tim Anderson relaunched coverage of 11 large-cap U.S. pharma and biotech names in a ...

Moderna Inc (MRNA) stock saw a modest uptick, ending the day at $41.58 which represents a slight increase of $2.20 or 5.59% from the prior close of $39.38. The stock opened at $39.71 and touched a low ...

https://www.tipranks.com/news/the-fly/anavex-price-target-raised-to-42-from-40-at-h-c-wainwright BofA reinstated coverage of Moderna (MRNA) with an Underperform ...

Moderna Inc (MRNA) stock saw a decline, ending the day at $40.13 which represents a decrease of $-0.30 or -0.74% from the prior close of $40.43. The stock opened at $40.35 and touched a low of $39.79 ...

For Moderna (MRNA), BofA noted “it was a tough time to be a vaccine company,” even if Robert F. Kennedy Jr. doesn’t become head of the Department of Health and Human Services. It added that ...

Moderna (MRNA) shares tumble after Bank of America analysts reinstated its Underperform rating for the stock. In a broader note about the pharmaceutical and biotech spaces, Bank of America's team ...

BofA reinstated coverage of Moderna (MRNA) with an Underperform rating and $41 price target calling it “a tough time to be a vaccines company,” citing COVID revenue stream uncertainty even if ...

Analysts issued an Underperform rating for shares while reluanching coverage of large-cap U.S. pharma and biotech names. Warren Buffett tells people to buy an S&P 500 index fund. A celebrity tech ...

Moderna (MRNA) shares tumble after Bank of America analysts reinstated its Underperform rating for the stock. In a broader note about the pharmaceutical and biotech spaces, Bank of America's team it's ...